374 related articles for article (PubMed ID: 26561214)
1. Probiotics are helpful in hepatic encephalopathy: a meta-analysis of randomized trials.
Saab S; Suraweera D; Au J; Saab EG; Alper TS; Tong MJ
Liver Int; 2016 Jul; 36(7):986-93. PubMed ID: 26561214
[TBL] [Abstract][Full Text] [Related]
2. Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis.
Cao Q; Yu CB; Yang SG; Cao HC; Chen P; Deng M; Li LJ
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):9-16. PubMed ID: 29428113
[TBL] [Abstract][Full Text] [Related]
3. Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.
Prakash RK; Kanna S; Mullen KD
Clin Ther; 2013 Sep; 35(9):1458-73. PubMed ID: 23972578
[TBL] [Abstract][Full Text] [Related]
4. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
Agrawal A; Sharma BC; Sharma P; Sarin SK
Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
Mittal VV; Sharma BC; Sharma P; Sarin SK
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis.
Luo M; Li L; Lu CZ; Cao WK
Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1250-7. PubMed ID: 21971378
[TBL] [Abstract][Full Text] [Related]
7. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
Sharma P; Sharma BC; Agrawal A; Sarin SK
J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
[TBL] [Abstract][Full Text] [Related]
8. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy.
Ziada DH; Soliman HH; El Yamany SA; Hamisa MF; Hasan AM
Arab J Gastroenterol; 2013 Sep; 14(3):116-22. PubMed ID: 24206740
[TBL] [Abstract][Full Text] [Related]
9. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
[TBL] [Abstract][Full Text] [Related]
10. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.
Sharma P; Sharma BC; Puri V; Sarin SK
Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):506-11. PubMed ID: 18467909
[TBL] [Abstract][Full Text] [Related]
11. The Effects of Probiotics and Symbiotics on Risk Factors for Hepatic Encephalopathy: A Systematic Review.
Viramontes Hörner D; Avery A; Stow R
J Clin Gastroenterol; 2017 Apr; 51(4):312-323. PubMed ID: 28059938
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy.
Shukla S; Shukla A; Mehboob S; Guha S
Aliment Pharmacol Ther; 2011 Mar; 33(6):662-71. PubMed ID: 21251030
[TBL] [Abstract][Full Text] [Related]
13. Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial.
Lunia MK; Sharma BC; Sharma P; Sachdeva S; Srivastava S
Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1003-8.e1. PubMed ID: 24246768
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of probiotics in the treatment of minimal hepatic encephalopathy: A systematic review and meta-analysis.
Wibawa IDN; Mariadi IK; Shalim CP; Sindhughosa DA
Clin Exp Hepatol; 2023 Jun; 9(2):146-153. PubMed ID: 37502435
[TBL] [Abstract][Full Text] [Related]
15. Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial.
Wang JY; Bajaj JS; Wang JB; Shang J; Zhou XM; Guo XL; Zhu X; Meng LN; Jiang HX; Mi YQ; Xu JM; Yang JH; Wang BS; Zhang NP
J Dig Dis; 2019 Oct; 20(10):547-556. PubMed ID: 31448533
[TBL] [Abstract][Full Text] [Related]
16. Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
Singh J; Sharma BC; Maharshi S; Puri V; Srivastava S
J Gastroenterol Hepatol; 2016 Jun; 31(6):1203-9. PubMed ID: 26716736
[TBL] [Abstract][Full Text] [Related]
17. Probiotics in management of hepatic encephalopathy.
Sharma BC; Singh J
Metab Brain Dis; 2016 Dec; 31(6):1295-1301. PubMed ID: 27121846
[TBL] [Abstract][Full Text] [Related]
18. Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis.
Moran S; López-Sánchez M; Milke-García MDP; Rodríguez-Leal G
World J Gastroenterol; 2021 Jun; 27(22):3050-3063. PubMed ID: 34168407
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of different drugs in the treatment of minimal hepatic encephalopathy: A network meta-analysis involving 826 patients based on 10 randomized controlled trials.
Cai XJ; Wang L; Hu CM
J Cell Biochem; 2018 Nov; 119(10):8336-8345. PubMed ID: 29932239
[TBL] [Abstract][Full Text] [Related]
20. Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
Singh J; Sharma BC; Puri V; Sachdeva S; Srivastava S
Metab Brain Dis; 2017 Apr; 32(2):595-605. PubMed ID: 28070704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
